AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renerve Ltd

0.105

-0.005-4.55%

Volume:155.52K

Turnover:16.33K

Market Cap:14.89M

PE:-4.37

High:0.105

Open:0.105

Low:0.105

Close:0.110

Loading ...

Overview Company News Filings

ReNerve Signs Agreement to Secure Regulatory Approval in India for Nerve Cuff Product; Shares Rise 10%

MT Newswires Live

BUZZ-Australia's ReNerve gains on partnership with Indian firm

BRIEF-ReNerve Formed A Strategic Partnership With Netcentrix Ventures

Renerve - Formed a Strategic Partnership With Netcentrix Ventures

THOMSON REUTERS

Renerve Reports Positive Results from Nerve Repair Comparative Study

MT Newswires Live

BUZZ-Australia's ReNerve hits record high on device's positive clinical trial results

ASX Biggest Gainers

MT Newswires Live

ReNerve study shows major patient outcome benefits of NervAlign nerve cuff

ReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low

MT Newswires Live

ReNerve Receives Additional Tax Incentive Refund; Shares Hit All-Time Low

MT Newswires Live

ReNerve Signs Distribution Agreement With Imbiomex for Nerve Repair Product; Shares Down 5%

MT Newswires Live

BRIEF-Renerve Enters Into Partnership For Nervalign® Nerve Cuff In Mexico

Renerve Ltd - Renerve Enters Partnership for Nervalign® Nerve Cuff in Mexico

THOMSON REUTERS

Cann Group Chair Steps Down

MT Newswires Live

Renerve Says Sales Jump 260% in December 2024 Quarter; Shares Rise 7%

MT Newswires Live

BRIEF-Renerve Signs Exclusive Partnership With Supplier In Middle East

Renerve Ltd - Signs Exclusive Partnership With Supplier in Middle East to Further Accelerate International Expansion

THOMSON REUTERS

BRIEF-Renerve Signs Exclusive Distribution Agreement With Accession Medical Supplies

Renerve Ltd - Signs Exclusive Distribution Agreement With Accession Medical Supplies

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNV.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","market":"AU","secType":"STK","nameCN":"Renerve Ltd","latestPrice":0.105,"timestamp":1745382924443,"preClose":0.11,"halted":0,"volume":155524,"delay":0,"nameEN":"Renerve Ltd","floatShares":63980367,"shares":141837806,"eps":-0.024044,"marketStatus":"Trading","change":-0.005,"latestTime":"04-23 14:55:32 AEST","open":0.105,"high":0.105,"low":0.105,"amount":16330,"amplitude":0,"askPrice":0.105,"askSize":129684,"bidPrice":0.1,"bidSize":150000,"shortable":3,"etf":0,"ttmEps":-0.024044,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745388000000},"marketStatusCode":2,"adr":0,"listingDate":1732194000000,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1745366400000,1745388000000]],"volumeRatio":2.145379,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","floatShares":63980367,"roa":"--","roe":"--","lyrEps":-0.031377,"volumeRatio":2.145379,"shares":141837806,"dividePrice":0,"high":0.105,"amplitude":0,"preClose":0.11,"low":0.105,"week52Low":0.099,"pbRate":"2.14","psRate":"61.73","week52High":0.22,"institutionHeld":0,"latestPrice":0.105,"committee":0.072639,"eps":-0.024044,"divideRate":0,"volume":155524,"delay":0,"ttmEps":-0.024044,"open":0.105,"prevYearClose":0.175,"prevWeekClose":0.105,"prevMonthClose":0.13,"prevQuarterClose":0.13,"fiveDayClose":0.105,"twentyDayClose":0.13,"sixtyDayClose":0.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNV.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526726573","title":"ReNerve Signs Agreement to Secure Regulatory Approval in India for Nerve Cuff Product; Shares Rise 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526726573","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526726573?lang=en_us&edition=fundamental","pubTime":"2025-04-10 11:16","pubTimestamp":1744255004,"startTime":"0","endTime":"0","summary":"Renerve  signed an agreement with information technology services provider NetCentrix Ventures to pursue regulatory approval for its nerve cuff product NervAlign in India, according to a Thursday filing with the Australian bourse.Under the deal, NetCentrix will assist ReNerve with testing, validation, and regulatory approvals through its Indian government partnerships, the filing said.Shares of the company rose 10% in recent Thursday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","RNV.AU"],"gpt_icon":0},{"id":"2526676375","title":"BUZZ-Australia's ReNerve gains on partnership with Indian firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2526676375","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526676375?lang=en_us&edition=fundamental","pubTime":"2025-04-10 10:18","pubTimestamp":1744251486,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's ReNerve gains on partnership with Indian firm** Shares of ReNerve RNV.AX rise 9.5% to A$0.115** Stock set for its strongest session since March 28, if current trends hold** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030** Stock down 34.3% YTD, including current session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nL3N3QO085:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","RNV.AU"],"gpt_icon":0},{"id":"2526260043","title":"BRIEF-ReNerve Formed A Strategic Partnership With Netcentrix Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2526260043","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526260043?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:40","pubTimestamp":1744245621,"startTime":"0","endTime":"0","summary":"BRIEF-ReNerve Formed A Strategic Partnership With Netcentrix VenturesApril 10 (Reuters) - ReNerve Ltd RNV.AX:FORMED A STRATEGIC PARTNERSHIP WITH NETCENTRIX VENTURESFurther company coverage: RNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QN1QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2526340037","title":"Renerve - Formed a Strategic Partnership With Netcentrix Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2526340037","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526340037?lang=en_us&edition=fundamental","pubTime":"2025-04-10 07:30","pubTimestamp":1744241425,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN1QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2522590223","title":"Renerve Reports Positive Results from Nerve Repair Comparative Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522590223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522590223?lang=en_us&edition=fundamental","pubTime":"2025-03-28 13:49","pubTimestamp":1743140971,"startTime":"0","endTime":"0","summary":"Renerve  said that a recent comparative study showed that patients undergoing peripheral nerve surgery who used its NervAlign nerve cuff saw a major decrease in post-surgery pain compared to patients who did not use the nerve cuff, according to a Friday Australian bourse filing.Patients who were treated with the nerve cuff were more likely to indicate they would have their procedure again.The nerve cuff is designed to protect repaired and regenerating nerves during the healing process after peripheral nerve injuries or repair surgery, per the filing.Its shares surged over 31% on market close on Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2522556036","title":"BUZZ-Australia's ReNerve hits record high on device's positive clinical trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522556036","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522556036?lang=en_us&edition=fundamental","pubTime":"2025-03-28 11:06","pubTimestamp":1743131206,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's ReNerve hits record high on device's positive clinical trial results** ReNerve RNV.AX swells 98.8% to a record high of A$0.220; last up 40.9%** Stock set for biggest ever intraday pct gain** Medical devices maker says patients using its NervAlign Nerve Cuff, which aids regeneration of peripheral nerves after surgery or injury, reported significantly lower post-surgery pain** RNV set to end the quarter 11.4% lower** About 4.5 mln shares traded in stock's busiest session ever** RNV loses 5.7% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3N3QB07C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2522156569","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2522156569","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522156569?lang=en_us&edition=fundamental","pubTime":"2025-03-28 10:01","pubTimestamp":1743127305,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Friday:Renerve : +40.9%, AU$0.155Elementos : +19.1%, AU$0.081ADX Energy : +16.7%, AU$0.028Recharge Metals : +16.7%, AU$0.014RAREX : +15%, AU$0.023Neurizon Therapeutics : +14.3%, AU$0.12Black Cat Syndicate : +14%, AU$0.895Adneo : +14%, AU$0.049Caprice Resources : +13.7%, AU$0.083New Murchison Gold : +13.3%, AU$0.017","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU","BC8.AU","BK7095","NUZ.AU","AD1.AU","REE.AU","ELT.AU","ADX.AU","BK7503","BK7126","BK7096","BK7002","BK7142","CRS.AU","NMG.AU","BK7104","REC.AU"],"gpt_icon":0},{"id":"2522653645","title":"ReNerve study shows major patient outcome benefits of NervAlign nerve cuff","url":"https://stock-news.laohu8.com/highlight/detail?id=2522653645","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522653645?lang=en_us&edition=fundamental","pubTime":"2025-03-28 08:50","pubTimestamp":1743123055,"startTime":"0","endTime":"0","summary":"Advanced nerve repair and regeneration solutions specialist ReNerve  has identified significant benefits for patient outcomes when using its NervAlign Nerve Cuff technology.A recent study found that patients undergoing peripheral nerve surgery with the NervAlign Nerve Cuff experienced a major decrease in post-surgery pain measures compared to surgery in which the product was not used.The investigation also found that average post-operative pain scores decreased from 7.1 to 0.4 with the Nerve Cuff, compared to a reduction from 7.1 to 3.3 without it.ReNerv developed the NervAlign Nerve Cuff to help protect repaired and regenerating nerves during the healing process after peripheral nerve injuries or surgery.NervAlign is naturally absorbed into the body within six months, leaving only regenerated and repaired tissue.The study – presented this week at the American College of Foot and Ankle Surgeons annual conference in Arizona – also found that patients treated with the Nerve Cuff reported","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Renerve-ASX-RNV-Material-Benefits-NervAlign-Nerve-Cuff.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Renerve-ASX-RNV-Material-Benefits-NervAlign-Nerve-Cuff.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/renerve-study-major-patient-outcome-benefits-nervalign-nerve-cuff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2518943081","title":"ReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2518943081","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518943081?lang=en_us&edition=fundamental","pubTime":"2025-03-12 10:25","pubTimestamp":1741746333,"startTime":"0","endTime":"0","summary":"ReNerve  received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2517141086","title":"ReNerve Receives Additional Tax Incentive Refund; Shares Hit All-Time Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2517141086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517141086?lang=en_us&edition=fundamental","pubTime":"2025-03-07 10:12","pubTimestamp":1741313523,"startTime":"0","endTime":"0","summary":"ReNerve  received an additional AU$139,537 in research and development tax incentives following an assessment of the company's overseas research activities, bringing its total refund to AU$516,606, according to a Friday filing with the Australian bourse.The company said it is working and developing products aimed to provide a complete range of products for peripheral nerve repair and replacement.The company's shares were down almost 4% in recent Friday trade, earlier hitting an all-time low.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2514843804","title":"ReNerve Signs Distribution Agreement With Imbiomex for Nerve Repair Product; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843804","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843804?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:11","pubTimestamp":1740629463,"startTime":"0","endTime":"0","summary":"ReNerve  signed an exclusive distribution partnership agreement with Imbiomex to progress its nerve repair biomaterial product, NervAlign Nerve Cuff, inMexico, according to a Thursday Australian bourse filing.The two companies have now started the regulatory application process to achieve market approval for the product, following which Imbiomex will market and sell the product in Mexico, the filing added.The company's shares were down nearly 5% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2514381692","title":"BRIEF-Renerve Enters Into Partnership For Nervalign® Nerve Cuff In Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381692","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381692?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:45","pubTimestamp":1740620752,"startTime":"0","endTime":"0","summary":"BRIEF-Renerve Enters Into Partnership For Nervalign® Nerve Cuff In MexicoFeb 27 (Reuters) - ReNerve Ltd RNV.AX:RENERVE ENTERS PARTNERSHIP FOR NERVALIGN® NERVE CUFF IN MEXICOFurther company coverage: RNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","RNV.AU"],"gpt_icon":0},{"id":"2514899217","title":"Renerve Ltd - Renerve Enters Partnership for Nervalign® Nerve Cuff in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2514899217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514899217?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:47","pubTimestamp":1740610047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2510481613","title":"Cann Group Chair Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2510481613","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510481613?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:26","pubTimestamp":1739226392,"startTime":"0","endTime":"0","summary":"Cann Group  Chair Julian Chick has resigned, effective Monday, according to a same-day filing with the Australian bourse.Chick's resignation was due to his expanded role as a full-time executive at ReNerve , per the filing.Doug Rathbone will be filling the role of interim chair, the company said, adding that it has identified \"several suitable external candidates\" as a potential successor.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAN.AU","RNV.AU"],"gpt_icon":1},{"id":"2507215508","title":"Renerve Says Sales Jump 260% in December 2024 Quarter; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507215508","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507215508?lang=en_us&edition=fundamental","pubTime":"2025-01-29 12:34","pubTimestamp":1738125248,"startTime":"0","endTime":"0","summary":"Renerve  said its sales for the fiscal quarter ended Dec. 31, 2024, came in at AU$52,000, representing a 260% increase from a year earlier, according to a Wednesday Australian bourse filing.The company reached an exclusive distribution agreement with Accession Medical Supplies for the sales and marketing of NervAlign Nerve Cuff in Hong Kong and Macau in December 2024, the filing said. It also entered an exclusive distribution agreement with Union MediScience in the Middle East, covering Bahrain, Saudi Arabia, Kuwait, UAE, and Qatar.The company said it continues to focus on expanding sales of NervAlign Nerve Cuff in its core US market.A clinical study investigating NervAlign on neurectomies repair is ongoing, with data expected to be released late in the third quarter of fiscal 2025, per the filing.The firm's shares rose past 7% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNV.AU"],"gpt_icon":0},{"id":"2490503506","title":"BRIEF-Renerve Signs Exclusive Partnership With Supplier In Middle East","url":"https://stock-news.laohu8.com/highlight/detail?id=2490503506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490503506?lang=en_us&edition=fundamental","pubTime":"2024-12-10 09:12","pubTimestamp":1733793155,"startTime":"0","endTime":"0","summary":"BRIEF-Renerve Signs Exclusive Partnership With Supplier In Middle EastDec 10 (Reuters) - ReNerve Ltd RNV.AX:SIGNS EXCLUSIVE PARTNERSHIP WITH SUPPLIER IN MIDDLE EAST TO FURTHER ACCELERATE INTERNATIONAL EXPANSIONFurther company coverage: RNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nFWN3NA1D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2490086089","title":"Renerve Ltd - Signs Exclusive Partnership With Supplier in Middle East to Further Accelerate International Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2490086089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490086089?lang=en_us&edition=fundamental","pubTime":"2024-12-10 06:23","pubTimestamp":1733782986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNV.AU","BK7126"],"gpt_icon":0},{"id":"2488293588","title":"BRIEF-Renerve Signs Exclusive Distribution Agreement With Accession Medical Supplies","url":"https://stock-news.laohu8.com/highlight/detail?id=2488293588","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488293588?lang=en_us&edition=fundamental","pubTime":"2024-12-03 08:50","pubTimestamp":1733187052,"startTime":"0","endTime":"0","summary":"BRIEF-Renerve Signs Exclusive Distribution Agreement With Accession Medical SuppliesDec 3 (Reuters) - ReNerve Ltd RNV.AX:SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT WITH ACCESSION MEDICAL SUPPLIESFurther company coverage: RNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N311D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","RNV.AU"],"gpt_icon":0},{"id":"2488984680","title":"Renerve Ltd - Signs Exclusive Distribution Agreement With Accession Medical Supplies","url":"https://stock-news.laohu8.com/highlight/detail?id=2488984680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488984680?lang=en_us&edition=fundamental","pubTime":"2024-12-03 06:26","pubTimestamp":1733178374,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N311D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","RNV.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNV.AU\",market:\"AU\",,,undefined,":[]}}